The Path
AI therapy platform for proactive mental wellness and emotional resilience
$14.3MSeed
Role not disclosedPM
Prime Movers Lab
Activity from announced rounds
Activity in this selectionUnited States
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $774.3M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionHark
Building advanced personalized intelligence and next-generation hardware for humans and machines
$700MSeries A
Role not disclosedGilgamesh Pharma
Develops novel chemical entities for psychiatric and neurological disorders
$60MSeries A
Role not disclosed